Orphit Overview

  • Founded
  • 2015
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Orphit General Information

Description

Provider of medical treatment for orphan and rare diseases. The company develops medical drug for alzheimer disease, brain tumors and other brain related diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphit Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business Completed Out of Business
2. Grant 14-Jun-2017 0000 Completed Startup
1. Accelerator/Incubator 09-Jun-2015 Completed Startup
To view Orphit’s complete valuation and funding history, request access »

Orphit Patents

Orphit Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3091163-B1 Thymulin analogue peptide (pat) for use in the treatment of vascular cerebral accidents Active 28-Dec-2018 000000000
FR-3091163-A1 Thymulin analogue peptide (pat) for use in the treatment of vascular accidents Granted 28-Dec-2018 000000000
US-20160074463-A1 Use of the pat nonapeptide in the treatment and prevention of neurodegenerative diseases Granted 12-Jul-2010 000000000 0
US-9468662-B2 Use of the pat nonapeptide in the treatment and prevention of neurodegenerative diseases Expired - Fee Related 12-Jul-2010 A61K38/08

Orphit Executive Team (1)

Name Title Board Seat Contact Info
Frederic Mourlane Ph.D Project Director
To view Orphit’s complete executive team members history, request access »